Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IONS
Stock Latest News
The Fly
Ionis Pharmaceuticals price target raised to $111 from $104 at Oppenheimer
3d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $86 from $83 at Stifel
3d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $100 from $95 at RBC Capital
4d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $125 from $120 at H.C. Wainwright
4d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $115 from $106 at Barclays
4d ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks
4d ago
IONS
Premium
Ratings
Analyst Reiterates Buy Rating on Ionis Pharmaceuticals, Maintains $105 Price Target on Strong Q1 and Upgraded Olezarsen Outlook
4d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals reports Q1 EPS (56c), consensus (77c)
5d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals raises FY26 revenue view $875M-$900M from $800M-$825M
5d ago
IONS
Premium
The Fly
Ionis partner GSK announces bepirovirsen NDA accepted for priority review
6d ago
GSK
IONS
Premium
Pre-Earnings
Ionis Pharmaceuticals Inc. (IONS) Q1 Earnings Cheat Sheet
7d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $108 from $110 at TD Cowen
11d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Advancing Neurology Franchise Underscored by Zilganersen’s Strong Phase III Data in Alexander Disease
12d ago
IONS
Premium
Company Announcements
Ionis Expands Its Rare Epilepsy Pipeline With New ASCEND Trial in Dravet Syndrome
12d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $130 from $95 at Morgan Stanley
12d ago
IONS
Premium
The Fly
Ionis announces additional results from zilganersen study in AxD
13d ago
IONS
Premium
Company Announcements
Ionis Highlights Positive Zilganersen Data in Alexander Disease
13d ago
8K
IONS
Premium
The Fly
Ionis Pharmaceuticals initiated with a Buy at Canaccord
13d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals initiated with a Buy at Canaccord
13d ago
IONS
Premium
The Fly
Nike downgraded, IBM initiated: Wall Street’s top analyst calls
24d ago
BDX
CCC
Premium
The Fly
Ionis Pharmaceuticals resumed with an Outperform at Raymond James
24d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $111 from $100 at BofA
25d ago
IONS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
